Tianyang Yun

ORCID: 0000-0002-0717-9117
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Lung Cancer Diagnosis and Treatment
  • Lung Cancer Treatments and Mutations
  • Cardiac tumors and thrombi
  • Nanoplatforms for cancer theranostics
  • Nanoparticle-Based Drug Delivery
  • Lung Cancer Research Studies
  • Head and Neck Cancer Studies
  • Graphene and Nanomaterials Applications
  • Esophageal Cancer Research and Treatment
  • Cancer therapeutics and mechanisms
  • Cancer-related gene regulation
  • Parkinson's Disease and Spinal Disorders
  • Cardiac Arrhythmias and Treatments
  • Pulmonary Hypertension Research and Treatments
  • Cardiac Valve Diseases and Treatments
  • Epigenetics and DNA Methylation
  • Quinazolinone synthesis and applications
  • Radiomics and Machine Learning in Medical Imaging
  • Lanthanide and Transition Metal Complexes
  • Atrial Fibrillation Management and Outcomes
  • Myasthenia Gravis and Thymoma
  • PI3K/AKT/mTOR signaling in cancer
  • Neuroendocrine Tumor Research Advances

Chinese PLA General Hospital
2014-2024

Chinese People's Liberation Army
2018-2019

People's Liberation Army No. 150 Hospital
2018-2019

Hainan Branch of People's Liberation Army General Hospital
2019

National Cancer Center
2014

Esophageal squamous cell carcinoma (ESCC) is one of the most common malignancies worldwide. Both genetic and epigenetic changes are involved in esophageal carcinogenesis. CHFR methylation has been found frequently different cancers regarded as a marker taxane sensitivity. was 0% (0/16) normal mucosa, 2.9% (1/34) grade I dysplasia, (0/8) II 12.5% (1/8) III dysplasia 45% (49/109) invasive cancer. When treated with docetaxel or paclitaxel, viability lower methylated cancer cells than...

10.18632/genesandcancer.46 article EN Genes & Cancer 2014-12-31

Robotic thymectomy has been suggested a feasible and safe approach for myasthenia gravis (MG). Few investigations have revealed the independent effect of robotic without confounding impact immunosuppressive (IM) therapy.Between May 2009 December 2012, extended was carried out patients with diagnosis MG. The clinical data, subsequent neurological therapy postintervention status were collected.Data 37 cases available analysis. mean follow-up 70.0±13.3 months. median age 40 years. Twelve...

10.21037/jtd.2017.12.07 article EN Journal of Thoracic Disease 2018-01-01

Utilizing the permeability enhancement and irreversible biomolecule denaturation caused by hyperthermia, photothermal-chemo synergistic therapy has shown great potential in clinical cancer treatment.The objective of this study was to provide a novel controlled drug release method improve efficiency therapy.HCT116 tumor-bearing mice were selected as modal for theranostics efficiency. The T2 T1 magnetic resonance imaging contrast switch studied vivo. Analyses tumor growth carried out evaluate...

10.2147/ijn.s182206 article EN cc-by-nc International Journal of Nanomedicine 2018-10-01

<title>Abstract</title> Here we examined whether Osimertinib (OSI) resistance which due to induced autophagy could be reversed by inhibiting with Pantoprazole. The effects of OSI ± pantoprazole were in four different non-small-cell lung cancer (NSCLC) cell lines, along two human xenograft models. on and drug evaluated. Alterations <italic>PI3K/Akt/mTOR</italic> pathway activation also Combination resulted decreased proliferation tumor inhibition NSCLC cells compared single agent therapy....

10.21203/rs.3.rs-3868429/v1 preprint EN cc-by Research Square (Research Square) 2024-02-06

To analyze the clinicopathological characteristics and risk factors of 4L lymph node metastasis in left non-small cell lung cancer.

10.12122/j.issn.1673-4254.2020.12.14 article EN Nanfang Yike Daxue xuebao 2020-12-30

In order to analyze the feasibility of pulmonary lobectomy for non-small cell lung cancer (NSCLC) in early period after percutaneous coronary intervention (PCI), current study was designed compare perioperative characteristics and prognostic performance patients with within 3 months or later PCI.This enrolled 349 simultaneously NSCLC stenosis. There were 198 151 PCI, respectively.Age all 62 [53-75] years. no difference demographic characteristics, medical histories, locations stent numbers...

10.21037/tcr.2019.09.23 article EN Translational Cancer Research 2019-09-01

Tumor microenvironment-responsive nanocomposites have great potential for synergistic tumor ablation with outstanding efficiency. Here, a pH- and redox-responsive CoOOH-doxorubicin nanocomposite is established programmed tri-model ablation. The CoOOH will decompose in the acidic glutathione-rich microenvironment, releasing doxorubicin chemotherapy Co2+ chemodynamic therapy, simultaneously. Then, residual nanosheet can convert near-infrared laser to heat, inducing photothermal therapy. shows...

10.2139/ssrn.4621853 preprint EN 2023-01-01

Background: In order to analyze the feasibility of pulmonary lobectomy for non-small cell lung cancer (NSCLC) in early period after percutaneous coronary intervention (PCI), current study was designed compare perioperative characteristics and prognostic performance patients with within 3 months or later PCI. Methods: This enrolled 349 simultaneously NSCLC stenosis. There were 198 151 PCI, respectively. Results: Age all 62 [53–75] years. no difference demographic characteristics, medical...

10.21037/31860 article EN Translational Cancer Research 2019-09-25
Coming Soon ...